Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19

Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19

Submitted by admin on March 25, 2020 - 11:59pm
Source: 
Motley Fool
News Tags: 
Gilead Sciences
remdesivir
FDA
orphan drugs
COVID-19
Headline: 
Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19
snippet: 

Gilead Sciences (NASDAQ: GILD) has asked the Food and Drug Administration to rescind the orphan drug designation it was awarded for remdesivir as a treatment for COVID-19, the disease caused by the new coronavirus.

Do Not Allow Advertisers to Use My Personal information